Statistics for The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic Agents
Total visits
views | |
---|---|
The α- and β-Adrenergic Antagonist Controversy with Sympathomimetic Agents | 265 |
Total visits per month
views | |
---|---|
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
File Visits
views | |
---|---|
nihms935777.pdf | 242 |
Top country views
views | |
---|---|
United States | 207 |
Germany | 7 |
Sweden | 7 |
Ukraine | 7 |
Russia | 4 |
Canada | 3 |
China | 3 |
United Kingdom | 2 |
Vietnam | 2 |
Cyprus | 1 |
France | 1 |
Lithuania | 1 |
Latvia | 1 |
Malaysia | 1 |
Portugal | 1 |
Uzbekistan | 1 |
Top city views
views | |
---|---|
Wilmington | 50 |
Fairfield | 43 |
Ann Arbor | 19 |
Houston | 12 |
White Plains | 10 |
Cambridge | 9 |
Jacksonville | 7 |
Kiev | 7 |
Kiez | 6 |
Stockholm | 5 |
San Francisco | 4 |
Augusta | 3 |
Chicago | 3 |
Saint Petersburg | 3 |
Toronto | 3 |
Beijing | 2 |
Concord | 2 |
Dong Ket | 2 |
Seattle | 2 |
Bloomsbury | 1 |
Brooklyn | 1 |
Gunzenhausen | 1 |
Kalmar | 1 |
Lake Mary | 1 |
Linda-a-velha | 1 |
Moscow | 1 |
Norrtälje | 1 |
Overland Park | 1 |
Paris | 1 |
Philadelphia | 1 |
Riga | 1 |
Scottsdale | 1 |
Seremban | 1 |
Shenzhen | 1 |
Tashkent | 1 |
Vilnius | 1 |
Warrington | 1 |
Washington | 1 |